In neonatal rats, MOR activation at higher doses is generally associated with reduction in ventilation and breathing frequency, which are hallmarks of opioid-induced respiratory depression (Greer et al., 1995; Colman and Miller, 2001). This evidence concerns the gene OPRM1 and respiratory depression.